| Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies (NCT04888936) | National Cancer Institute (NCI) | 2022-04-25 |
| French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome (NCT05308927) | Novo Nordisk A/S | 2022-03-16 |
| Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome (NCT05202210) | University Hospital, Toulouse | 2022-01-26 |
| Solid Tumors in RASopathies (NCT05761314) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-10-12 |
| Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies (NCT06331117) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-04-22 |
| Prevalence and Characterization of Pain in RASopathies (NCT06355622) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-01-27 |
| Joint and Hematologic Disorders of Noonan Syndrome: French Descriptive Cross-sectional Study (NCT06550635) | University Hospital, Brest | 2019-07-02 |
| GROWing Up With Rare GENEtic Syndromes (NCT04463316) | dr. Laura C. G. de Graaff-Herder | 2018-10-01 |
| Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome) (NCT03435627) | Novo Nordisk A/S | 2018-02-26 |
| RASopathy Biorepository (NCT04395495) | Children's Hospital Medical Center, Cincinnati | 2017-06-27 |
| Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome (NCT02713945) | University Hospital, Toulouse | 2017-01-25 |
| Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes (NCT02486731) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-12-16 |
| Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome (NCT01927861) | Novo Nordisk A/S | 2013-08-19 |
| Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques (NCT07336394) | Chinese Academy of Medical Sciences, Fuwai Hospital | 2010-01-01 |
| Observational Prospective Study on Patients Treated With Norditropin® (NCT00960128) | Novo Nordisk A/S | 2006-04-01 |
| Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome (NCT00452725) | Sanofi | 1997-10-01 |
| Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome (NCT01529840) | Novo Nordisk A/S | 1990-06-01 |
| Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome (NCT00351221) | Insmed Incorporated | |